Tranche 1 and 2 warrants
Company: Core Scientific
The claim, verbatim
Existing shareholders will receive 3-year Tranche 1 warrants exercisable at $6.81 and 5-year Tranche 2 warrants exercisable at $8.72. Full exercise of Tranche 1 would generate about $670 million of cash.
Source (primary)
core-scientific 8-K exhibit (d735123dex992.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-13)Live source ↗
Quote: “Tranche 1 Warrants, which, if exercised in full, would generate ~$670 million of cash, deleveraging the balance sheet”
How we checked this
Checked on November 14, 2026. The cited source supports every part of this claim.
The document describes 3-year Tranche 1 warrants at $6.81 and 5-year Tranche 2 warrants at $8.72, and says full Tranche 1 exercise would generate ~$670 million; note it elsewhere describes Tranche 2 as exercisable for $0.01 once the stock trades above $8.72.
Confirmed in the source:
- Existing shareholders will receive Tranche 1 and Tranche 2 warrants
- Tranche 1 warrants are 3-year warrants
- Tranche 1 warrants are exercisable at $6.81 per share
- Tranche 2 warrants are 5-year warrants
- The document lists the Tranche 2 warrant exercise price as $8.72
- Full exercise of Tranche 1 warrants would generate about $670 million of cash
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/d735123dex992.htm) in full (29,831 characters, retrieved November 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d735123dex992.htm)
Quote: “Tranche 1 Warrants, which, if exercised in full, would generate ~$670 million of cash, deleveraging the balance sheet”